KalVista Pharmaceuticals ... (KALV)
NASDAQ: KALV
· Real-Time Price · USD
13.81
0.27 (1.99%)
At close: Jun 05, 2025, 3:59 PM
1.99% (1D)
| Bid | 13.04 |
| Market Cap | 686.57M |
| Revenue (ttm) | 1.21M |
| Net Income (ttm) | -175.87M |
| EPS (ttm) | -3.77 |
| PE Ratio (ttm) | -3.66 |
| Forward PE | -4.48 |
| Analyst | Buy |
| Ask | 14.45 |
| Volume | 357,867 |
| Avg. Volume (20D) | 591,190 |
| Open | 13.45 |
| Previous Close | 13.54 |
| Day's Range | 13.45 - 13.82 |
| 52-Week Range | 7.30 - 15.50 |
| Beta | 0.05 |
About KALV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KALV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KALV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+9.49%
KalVista Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
6 months ago
+8.28%
KalVista Pharmaceuticals shares are trading higher. HC Wainwright & Co. reiterated a Buy rating on the stock.
